methylprednisolone has been researched along with losartan potassium in 43 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (16.28) | 18.7374 |
| 1990's | 6 (13.95) | 18.2507 |
| 2000's | 14 (32.56) | 29.6817 |
| 2010's | 13 (30.23) | 24.3611 |
| 2020's | 3 (6.98) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Gerdes, H; Goebel, KM; von Manteuffel, G; Zehner, J | 1 |
| Gradowska, L; Grzeszczak, W; Jagiełło, R; Kokot, F; Lao, M; Wiecek, A; Wnuk, A | 1 |
| Cenacchi, A; Finelli, C; Fogli, M; Gamberi, B; Tura, S; Visani, G | 1 |
| Kerr, GE; Korst, DR; Meyer, RK; Shahidi, NT; Vitale, L; Wolf, RC | 1 |
| Calcagnini, G; Condorelli, M; Nabavi, F; Peschle, C; Rizzo, S; Sasso, GF | 1 |
| Condorelli, M; Galanie, A; Mastroberardino, G; Peschle, C; Ricci, S; Sasso, GF | 1 |
| Condorelli, M; Gordon, AS; Peschle, C; Rappaport, IA; Sasso, GF; Zanjani, ED | 1 |
| Dunn, CD; Hoover, EA; Kociba, GJ; Lange, RD | 1 |
| Gordon, MY; Hibbin, JA; Kearney, L | 1 |
| Akiyama, H; Ohashi, K; Onozawa, Y; Sakamaki, H; Takamoto, S; Tanikawa, S | 1 |
| Imai, Y; Kikuchi, M; Ohsaka, A; Sugahara, Y | 1 |
| Fukuoka, T; Imai, Y; Nakatani, A; Ohsaka, A; Takahashi, A | 1 |
| Cierpka, L; Gradowska, L; Grzeszczak, W; Jagiełło, R; Kokot, F; Kuśmierski, S; Lao, M; Wiecek, A | 1 |
| Hasegawa, Y; Higuchi, M; Imagawa, S; Kojima, H; Komeno, T; Mukai, HY; Nagasawa, T; Ninomiya, H; Okoshi, Y; Shimizu, S; Yoshida, C | 1 |
| Akbiyik, F; Beskonakli, E; Kaptanoglu, E; Okutan, O; Solaroglu, I; Surucu, HS | 1 |
| Bourantas, KL; Chaidos, A; Christou, L; Gouva, M; Kapsali, E; Panteli, K; Tsiara, SN | 1 |
| Bähr, M; Demmer, I; Diem, R; Ehrenreich, H; Maier, K; Merkler, D; Sättler, MB; Stadelmann, C | 1 |
| Aessopos, A; Deftereos, S; Farmakis, D; Floudas, H; Giakoumi, X; Grapsa, A; Polonifi, A; Polymeropoulos, E | 1 |
| Boran, BO; Colak, A; Kutlay, M | 1 |
| Büyükbayram, H; Cetin, A; Ceviz, A; Nas, K; Olmez, G | 1 |
| Del Priore, LV; Lobes, LA; Lopez, R; Ober, MD; Puklin, JE; Tsai, J; Young, T | 1 |
| Misirlioglu, M; Ozisik, K; Ozisik, P; Tuncer, S; Yildirim, E | 1 |
| Beskonakli, E; Okutan, O; Solaroglu, I; Taskin, Y | 1 |
| D'Agostino, L; D'Angelo, S; Olivieri, I; Palazzi, C; Petricca, A | 1 |
| Brenna, P; Caffino, L; Di Giulio, AM; Fumagalli, F; Gorio, A; Madaschi, L; Marfia, G; Racagni, G | 1 |
| Franco-Bourland, RE; Grijalva, I; Guízar-Sahagún, G; Ibarra, A; Madrazo, I; Martínez-Cruz, A; Rodríguez-Balderas, CA | 1 |
| Furuichi, K; Hara, A; Higuchi, M; Iwata, Y; Kaneko, S; Kitagawa, K; Kitajima, S; Okumura, T; Sakai, N; Toyama, T; Wada, T | 1 |
| Chang, CY; Chou, CM; Hsu, CY; Hsu, MF; Hung, KS; Juan, SH; Lee, YH; Sun, YY; Wang, CY; Xu, J; Yang, LY | 1 |
| Chen, S; Li, F; Liu, Z; Xiong, M; Yu, H; Zeng, Y | 1 |
| Pakravan, M; Sanjari, N | 1 |
| Bähr, M; Bittersohl, D; Ciupka, C; Diem, R; Fassbender, K; Görlitz, A; Hassenstein, A; Heesen, C; Hein, K; Hilgers, R; Käsmann-Kellner, B; Papanagiotou, P; Reith, W; Restemeyer, C; Sättler, MB; Schäffler, N; Scholz, K; Seitz, B; Sühs, KW | 1 |
| Azimi, AR; Najmi Varzaneh, F; Rezaei, N; Sahraian, MA | 1 |
| Alibai, E; Rahimi, A; Rezaianzadeh, A; Zand, F | 1 |
| Dast Borhan, Z; Dehghani, A; Mirmohammadsadeghi, A; Rahimi, M; Shahzamani, S; Shayegannejad, V | 1 |
| Beghi, E; Carignano, P; Costa, DD; Faccioli, F; Gorio, A; Messina, P; Pagliacci, C; Pupillo, E; Redaelli, T | 1 |
| Esfandiari, H; Ghahari, E; Pakravan, M; Sanjari, N | 1 |
| Boville, B; Hassan, N; Kovey, K; Ndika, A; Reischmann, D; Sterken, D | 1 |
| Bagheri, M; Entezari, M; Esmaeli, M; Etezad-Razavi, M; Kashkouli, MB; Nojomi, M; Pakdel, F; Razeghinejad, MR; Sanjari, MS; Shafiee, M; Yousefi, S | 1 |
| Pang, QJ; Xu, RJ; Yan, YQ | 1 |
| Abouei Mehrizi, MA; Bahadorkhan, G; Ganjeifar, B; Keykhosravi, E; Nakhaei, M; Rezaee, H; Tavallaii, A | 1 |
| Hassanzadeh, S; Jahangiri-Mehr, S; Vafapour, F | 1 |
| Albrecht, P; Beisse, F; Diem, R; Grotejohann, B; Heinrich, SP; Hug, MJ; Ihorst, G; Küchlin, S; Lagrèze, WA; Ungewiss, J; Wolf, S; Wörner, M | 1 |
8 trial(s) available for methylprednisolone and losartan potassium
| Article | Year |
|---|---|
A randomized, double-blind, phase 2 study of erythropoietin in optic neuritis.
Topics: Adult; Anti-Inflammatory Agents; Double-Blind Method; Erythropoietin; Evoked Potentials, Visual; Female; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Optic Nerve; Optic Neuritis; Retina; Tomography, Optical Coherence; Treatment Outcome; Visual Acuity; Visual Field Tests; Visual Fields; Young Adult | 2012 |
Efficacy of combination therapy with erythropoietin and methylprednisolone in clinical recovery of severe relapse in multiple sclerosis.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Combined Modality Therapy; Disability Evaluation; Erythropoietin; Female; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Statistics, Nonparametric; Young Adult | 2014 |
Erythropoietin plus methylprednisolone or methylprednisolone in the treatment of acute spinal cord injury: a preliminary report.
Topics: Acute Disease; Adolescent; Adult; Aged; Epoetin Alfa; Erythropoietin; Female; Hematinics; Humans; Male; Methylprednisolone; Middle Aged; Neuroprotective Agents; Recombinant Proteins; Spinal Cord Injuries; Treatment Outcome | 2014 |
A double-blind, placebo-controlled trial of adding erythropoietin to intravenous methylprednisolone for the treatment of unilateral acute optic neuritis of unknown or demyelinative origin.
Topics: Acute Disease; Adolescent; Adult; Demyelinating Diseases; Double-Blind Method; Drug Therapy, Combination; Erythropoietin; Female; Glucocorticoids; Humans; Infusions, Intravenous; Male; Methylprednisolone; Nerve Fibers; Optic Neuritis; Recombinant Proteins; Retinal Ganglion Cells; Tomography, Optical Coherence; Visual Acuity; Young Adult | 2015 |
Tolerability and efficacy of erythropoietin (EPO) treatment in traumatic spinal cord injury: a preliminary randomized comparative trial vs. methylprednisolone (MP).
Topics: Adolescent; Adult; Aged; Bayes Theorem; Cervical Vertebrae; Computer Simulation; Erythropoietin; Female; Humans; Italy; Male; Methylprednisolone; Middle Aged; Neuroprotective Agents; Single-Blind Method; Spinal Cord Injuries; Thoracic Vertebrae; Time Factors; Treatment Outcome; Young Adult | 2015 |
Erythropoietin as an adjunctive treatment for methanol-induced toxic optic neuropathy.
Topics: Administration, Intravenous; Adult; Drug Therapy, Combination; Erythropoietin; Follow-Up Studies; Glucocorticoids; Humans; Male; Methanol; Methylprednisolone; Middle Aged; Nerve Fibers; Optic Nerve Diseases; Retina; Treatment Outcome; Visual Acuity; Visual Fields | 2016 |
Traumatic optic neuropathy treatment trial (TONTT): open label, phase 3, multicenter, semi-experimental trial.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Color Vision; Dose-Response Relationship, Drug; Erythropoietin; Female; Glucocorticoids; Humans; Infusions, Intravenous; Male; Methylprednisolone; Middle Aged; Optic Nerve Diseases; Optic Nerve Injuries; Treatment Outcome; Visual Acuity; Young Adult | 2018 |
The effect of combination therapy with erythropoietin and methylprednisolone in patients with traumatic cervical spinal cord injury: a pilot randomized controlled trial.
Topics: Adult; Cervical Cord; Erythropoietin; Female; Humans; Male; Methylprednisolone; Pilot Projects; Spinal Cord Injuries | 2021 |
35 other study(ies) available for methylprednisolone and losartan potassium
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
[Glucocorticoid-induced effect of erythropoietin in haemolytic anaemia with uraemia and red cell enzyme deficiency (author's transl)].
Topics: Adult; Anemia, Hemolytic, Congenital Nonspherocytic; Deficiency Diseases; Erythrocytes; Erythropoietin; Female; Hemolytic-Uremic Syndrome; Humans; Male; Methylprednisolone; Pyruvate Kinase | 1978 |
[Level of erythropoietin and parathormone in blood plasma during acute rejection of kidney transplant].
Topics: Acute Disease; Adult; Erythropoietin; Female; Graft Rejection; Humans; Kidney Transplantation; Male; Methylprednisolone; Middle Aged; Parathyroid Hormone | 1991 |
Steroid-resistant acquired pure red cell aplasia: a partial remission induced by recombinant human erythropoietin.
Topics: Autoimmune Diseases; Drug Resistance; Erythropoietin; Female; Humans; Methylprednisolone; Middle Aged; Recombinant Proteins; Red-Cell Aplasia, Pure; Remission Induction | 1991 |
The role of growth hormone and thyroxine in erythropoietic restoration in hypophysectomized monkeys.
Topics: Animals; Bone Marrow; Bone Marrow Cells; Chromium Isotopes; Drug Interactions; Erythrocytes; Erythropoiesis; Erythropoietin; Female; Growth Hormone; Haplorhini; Hematocrit; Hemoglobins; Hypophysectomy; Iodine Isotopes; Iron; Iron Isotopes; Macaca; Methylprednisolone; Pituitary Gland; Plasma Volume; Thyroid Function Tests; Thyroxine | 1971 |
[Erythropoietin mediation of the erythropoietic effect of ACTH, hydrocortisone and prednisolone].
Topics: Adrenocorticotropic Hormone; Animals; Erythropoiesis; Erythropoietin; Female; Hydrocortisone; Methylprednisolone; Mice; Prednisolone | 1969 |
[On the minimal effective erythrostimulating doses of ACTH, hydrocortisone and prednisolone].
Topics: Adrenocorticotropic Hormone; Animals; Erythropoiesis; Erythropoietin; Female; Hydrocortisone; Methylprednisolone; Mice; Prednisolone | 1970 |
Mechanisms underlying 6-methyl-prednisolone influences on erythropoiesis.
Topics: Animals; Drug Synergism; Erythropoiesis; Erythropoietin; Female; Immune Sera; Iron Isotopes; Methylprednisolone; Mice; Mice, Inbred Strains; Polycythemia; Time Factors | 1972 |
Serum erythropoietin changes in cats with feline leukemia virus-induced erythroid aplasia.
Topics: Anemia, Aplastic; Animals; Cat Diseases; Cats; Erythropoietin; Female; Hematocrit; Leukemia; Leukemia Virus, Feline; Male; Methylprednisolone; Methylprednisolone Acetate; Specific Pathogen-Free Organisms | 1983 |
Effects of human marrow stromal cells on proliferation by human granulocytic (GM-CFC), erythroid (BFU-E) and mixed (Mix-CFC) colony-forming cells.
Topics: Bone Marrow Cells; Cell Differentiation; Cells, Cultured; Colony-Forming Units Assay; Colony-Stimulating Factors; Endothelium; Erythropoiesis; Erythropoietin; Fibroblasts; Granulocytes; Hematopoiesis; Hematopoietic Stem Cells; Humans; Macrophages; Methylprednisolone | 1983 |
Treatment of pure red cell aplasia after major ABO-incompatible bone marrow transplantation resistant to erythropoietin. Bone Marrow Transplantation Team.
Topics: ABO Blood-Group System; Adult; Bone Marrow Transplantation; Combined Modality Therapy; Drug Resistance; Drug Therapy, Combination; Erythropoietin; Histocompatibility; Humans; Immunoglobulins, Intravenous; Male; Methylprednisolone; Prednisolone; Red-Cell Aplasia, Pure; Time Factors | 1994 |
Evolution of severe aplastic anemia to myelodysplasia with monosomy 7 following granulocyte colony-stimulating factor, erythropoietin and high-dose methylprednisolone combination therapy.
Topics: Adult; Anemia, Aplastic; Chromosomes, Human, Pair 7; Drug Therapy, Combination; Erythropoietin; Glucocorticoids; Granulocyte Colony-Stimulating Factor; Humans; Male; Methylprednisolone; Monosomy; Myelodysplastic Syndromes | 1995 |
Sustained trilineage recovery and disappearance of abnormal chromosome clone in a patient with myelodysplastic syndrome following combination therapy with cytokines (granulocyte colony-stimulating factor and erythropoietin) and high-dose methylprednisolon
Topics: Anti-Inflammatory Agents; Chromosome Deletion; Cytokines; Drug Therapy, Combination; Erythropoietin; Granulocyte Colony-Stimulating Factor; Humans; Karyotyping; Male; Methylprednisolone; Middle Aged; Myelodysplastic Syndromes | 1996 |
Serum erythropoietin and parathyroid hormone concentrations in kidney transplant patients during acute graft rejection.
Topics: Adult; Antilymphocyte Serum; Azathioprine; Creatinine; Cyclosporine; Erythrocyte Count; Erythropoietin; Female; Ferritins; Graft Rejection; Hemoglobins; Humans; Immunosuppressive Agents; Iron; Kidney Transplantation; Male; Methylprednisolone; Parathyroid Hormone; Reference Values | 1996 |
A patient with acquired pure red cell aplasia showing a positive antiglobulin test and the presence of inhibitor against erythroid precursors.
Topics: Aged; Anti-Inflammatory Agents; Bone Marrow Examination; Coombs Test; Erythroid Precursor Cells; Erythropoietin; Humans; Male; Methylprednisolone; Prednisolone; Red-Cell Aplasia, Pure; Tumor Cells, Cultured | 2002 |
Erythropoietin exerts neuroprotection after acute spinal cord injury in rats: effect on lipid peroxidation and early ultrastructural findings.
Topics: Acute Disease; Animals; Disease Models, Animal; Erythropoietin; Lipid Peroxidation; Male; Methylprednisolone; Neuroprotective Agents; Rats; Rats, Wistar; Spinal Cord; Spinal Cord Injuries; Thiobarbituric Acid Reactive Substances; Time Factors; Trauma Severity Indices | 2004 |
Successful treatment of refractory anemia with a combination regimen containing recombinant human erythropoietin, low-dose methylprednisolone and nandrolone.
Topics: Aged; Androgens; Anemia; Anemia, Refractory; Anti-Inflammatory Agents; Blood Transfusion; Bone Marrow Cells; Drug Therapy, Combination; Erythrocytes; Erythropoietin; Female; Humans; Male; Methylprednisolone; Middle Aged; Myelodysplastic Syndromes; Nandrolone; Recombinant Proteins; Time Factors | 2004 |
Combined therapy with methylprednisolone and erythropoietin in a model of multiple sclerosis.
Topics: Animals; Drug Therapy, Combination; Electroretinography; Encephalomyelitis, Autoimmune, Experimental; Erythropoietin; Evoked Potentials, Visual; Female; Methylprednisolone; Multiple Sclerosis; Neuroprotective Agents; Optic Nerve; Optic Neuritis; Rats; Rats, Inbred BN; Recombinant Proteins; Retinal Ganglion Cells; Signal Transduction | 2005 |
Myelodysplastic syndrome associated with multiple autoimmune disorders.
Topics: Aged; Aged, 80 and over; Arthritis; Autoimmune Diseases; Blood Transfusion; Combined Modality Therapy; Dermatitis; Drug Therapy, Combination; Epoetin Alfa; Erythropoietin; Filgrastim; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Male; Methylprednisolone; Myelodysplastic Syndromes; Recombinant Proteins; Risk Assessment; Severity of Illness Index; Treatment Outcome; Vasculitis | 2005 |
Erythropoietin enhances neurological recovery after experimental spinal cord injury.
Topics: Animals; Disease Models, Animal; Erythropoietin; Humans; Male; Methylprednisolone; Motor Activity; Neurologic Examination; Neuroprotective Agents; Rats; Rats, Wistar; Recombinant Proteins; Recovery of Function; Spinal Cord Injuries; Time Factors | 2005 |
The effects of systemically administered methylprednisolone and recombinant human erythropoietin after acute spinal cord compressive injury in rats.
Topics: Animals; Erythropoietin; Methylprednisolone; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Recovery of Function; Spinal Cord Compression; Spinal Cord Injuries | 2006 |
Diagnostic and therapeutic challenges.
Topics: Adolescent; Anemia; Anti-Inflammatory Agents; Cardiomyopathies; Epoetin Alfa; Erythropoietin; Fluorescein Angiography; Humans; Injections; Laser Coagulation; Male; Methylprednisolone; Methylprednisolone Acetate; Muscular Dystrophy, Duchenne; Recombinant Proteins; Retinal Neovascularization; Vision Disorders; Vitrectomy; Vitreous Hemorrhage | 2006 |
Expression of antiapoptotic survivin and aven genes in rat heart tissue after traumatic brain injury.
Topics: Adaptor Proteins, Signal Transducing; Animals; Apoptosis Regulatory Proteins; Brain Injuries; DNA Primers; DNA, Complementary; Erythropoietin; Gene Expression Regulation; Heart; Methylprednisolone; Microtubule-Associated Proteins; Muscle Cells; Polymerase Chain Reaction; Rats; RNA; Survivin | 2006 |
Recombinant human erythropoietin decreases myeloperoxidase and caspase-3 activity and improves early functional results after spinal cord injury in rats.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Caspase 3; Erythropoietin; Female; Humans; Methylprednisolone; Neuroprotective Agents; Peroxidase; Rats; Rats, Wistar; Recombinant Proteins; Recovery of Function; Spinal Cord Injuries | 2007 |
Acute myositis in a patient with systemic sclerosis after the administration of darbepoetin alpha.
Topics: Acute Disease; Adrenal Cortex Hormones; Anti-Inflammatory Agents; Darbepoetin alfa; Dose-Response Relationship, Drug; Erythropoietin; Female; Hematinics; Humans; Injections, Subcutaneous; Methylprednisolone; Middle Aged; Myositis; Prednisone; Scleroderma, Systemic; Severity of Illness Index; Treatment Outcome | 2008 |
Single exposure to erythropoietin modulates Nerve Growth Factor expression in the spinal cord following traumatic injury: comparison with methylprednisolone.
Topics: Animals; Erythropoietin; Gene Expression Regulation; Glucocorticoids; Methylprednisolone; Nerve Growth Factor; Rats; Rats, Sprague-Dawley; Recovery of Function; RNA, Messenger; Spinal Cord; Spinal Cord Injuries; Time Factors | 2008 |
Lack of neuroprotection with pharmacological pretreatment in a paradigm for anticipated spinal cord lesions.
Topics: Analysis of Variance; Animals; Cyclosporine; Disease Models, Animal; Erythropoietin; Female; Locomotion; Melatonin; Methylprednisolone; Neuroprotective Agents; Postoperative Complications; Rats; Rats, Long-Evans; Recombinant Proteins; Recovery of Function; Spinal Cord; Spinal Cord Injuries; Time Factors | 2009 |
Combined pure red cell aplasia and autoimmune hemolytic anemia in systemic lupus erythematosus with anti-erythropoietin autoantibodies.
Topics: Adult; Anemia, Hemolytic, Autoimmune; Antibody Specificity; Autoantibodies; Bone Marrow; Cell Division; Cell Line; Erythroid Precursor Cells; Erythropoietin; Female; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Methylprednisolone; Prednisolone; Red-Cell Aplasia, Pure | 2008 |
Glucocorticoid protection of oligodendrocytes against excitotoxin involving hypoxia-inducible factor-1alpha in a cell-type-specific manner.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Analysis of Variance; Animals; Cell Death; Cells, Cultured; Chromatin Immunoprecipitation; Computer Simulation; Erythropoietin; Hypoxia-Inducible Factor 1, alpha Subunit; Immunoprecipitation; Methylprednisolone; Oligodendroglia; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction | 2010 |
Neuroprotection of erythropoietin and methylprednisolone against spinal cord ischemia-reperfusion injury.
Topics: Adult; Aged; Decompression, Surgical; Erythropoietin; Female; Humans; Male; Methylprednisolone; Middle Aged; Neuroprotective Agents; Reperfusion Injury; Retrospective Studies; Spinal Cord; Spinal Cord Compression; Spinal Cord Ischemia | 2011 |
Erythropoietin treatment for methanol optic neuropathy.
Topics: Administration, Intravenous; Administration, Oral; Adult; Anti-Inflammatory Agents; Erythropoietin; Humans; Male; Methanol; Methylprednisolone; Neuroprotective Agents; Optic Disk; Optic Nerve Diseases; Prednisolone; Solvents; Tomography, Optical Coherence; Visual Field Tests | 2012 |
Intravenous Ferumoxytol in Pediatric Patients With Iron Deficiency Anemia.
Topics: Adolescent; Anemia, Iron-Deficiency; Child; Child, Preschool; Erythropoietin; Female; Ferrosoferric Oxide; Hemoglobins; Humans; Infant; Infant, Newborn; Infusions, Intravenous; Male; Methylprednisolone; Pruritus; Retrospective Studies; Young Adult | 2017 |
Effects of erythropoietin for precaution of steroid-induced femoral head necrosis in rats.
Topics: Animals; Disease Models, Animal; Erythropoietin; Female; Femur Head; Femur Head Necrosis; Male; Methylprednisolone; Platelet Endothelial Cell Adhesion Molecule-1; Rats, Sprague-Dawley; Vascular Endothelial Growth Factor A | 2018 |
Delayed reversal of methanol-induced blindness in an adult by a combination of erythropoietin and a high dose of methylprednisolone: a case report.
Topics: Adult; Blindness; Erythropoietin; Humans; Iran; Male; Methanol; Methylprednisolone; Vision Disorders | 2023 |
Treatment With Erythropoietin for Patients With Optic Neuritis: Long-term Follow-up.
Topics: Erythropoietin; Follow-Up Studies; Humans; Methylprednisolone; Multiple Sclerosis; Optic Neuritis; Quality of Life; Visual Acuity | 2023 |